Category: COPD

Good News for Glaxo Inhaler

Patients with chronic obstructive pulmonary disease (COPD) taking GlaxoSmithKline’s Seretide were half as likely to die as those taking Pfizer’s Spiriva, according to a Glaxo-funded study.
But the dosage of the Glaxo drug used in the study (sold in this country as Advair) is not approved in the U.S. to treat COPD — and […]

Continued Read ...
Posted in Drugs, FDA, COPD  


RSS Health Care Blog News